Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder

FDA product code QFT · 3 cleared devices

Class 2 Obstetrics/Gynecology
Regulation
21 CFR 882.5803
Review panel
NE
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
No
Clearance span
2023-12-13 – 2025-06-13

A digital therapy device for Attention Deficit Hyperactivity Disorder (ADHD) is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.

↑